Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow Jrheum on BlueSky
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
LetterResearch Letter

Improving Human Papillomavirus-Related Cervical Cancer Screening in Patients With Systemic Lupus Erythematosus

Tiphaine Goulenok, Céline Mendes, Léa Dayan, Valentine Marie Ferre, Margot Bucau, Fatima Farhi, Thomas Papo and Karim Sacré
The Journal of Rheumatology December 2023, 50 (12) 1642-1644; DOI: https://doi.org/10.3899/jrheum.2022-1335
Tiphaine Goulenok
1Service de Médecine Interne, Hôpital Bichat, AP-HP;
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Tiphaine Goulenok
Céline Mendes
1Service de Médecine Interne, Hôpital Bichat, AP-HP;
RN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Léa Dayan
2Maison de santé pluriprofessionnelle Épinettes Grandes Carrières;
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Valentine Marie Ferre
3Service de Virologie, Hôpital Bichat, AP-HP;
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Margot Bucau
4Service de Pathologie, Hôpital Bichat, AP-HP;
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Margot Bucau
Fatima Farhi
1Service de Médecine Interne, Hôpital Bichat, AP-HP;
MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Papo
1Service de Médecine Interne, Hôpital Bichat, AP-HP;
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karim Sacré
1Service de Médecine Interne, Hôpital Bichat, AP-HP;
5Université Paris Cité, Centre de Recherche sur l’Inflammation, Inserm UMR1149, CNRS ERL8252, Faculté de Médecine site Bichat, Laboratoire d’Excellence Inflamex, Paris, France.
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Karim Sacré
  • For correspondence: karim.sacre@aphp.fr
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
PreviousNext
Loading

Article Figures & Data

Tables

    • View popup
    Table.

    Characteristics of patients with SLE at baseline.

    Up to Date,
    n = 76
    Not Up to Date,
    n = 66
    P
    Sociodemographics
        Age, yrs, median (IQR)43.0 (37.7-50.0)43.0 (33.0-51.0)0.47
        Healthcare insurance58 (76)49 (74)0.85
        Profession
            Senior executive11 (14)8 (12)0.81
            Intermediate occupation30 (39)12 (18)0.01
            Employee/worker8 (10)2 (3)0.11
            Student0 (0)2 (3)0.21
            Retired1 (1)0 (0)> 0.99
            Unemployed14 (18)26 (39)0.01
    SLE disease characteristicsa
        SLE duration, yrs, median (IQR)12.0 (5.0-22.0)8.5 (4.0-16.2)0.12
        Arthritis55 (72)45 (68)0.71
        Skin lesions48 (63)40 (61)0.86
        Class III/IV/V LN30 (39)25 (38)0.86
        SLEDAI, median (IQR)2 (0-4)2 (0-4)0.85
        Current prescription of HCQ67 (82)60 (91)0.78
        Current prescription of steroids39 (51)29 (44)0.40
        Current prescription of IS drugs23 (30)17 (26)0.58
    Sexual and behavior risk factors
        Lifetime sexual partners, median (IQR)2.5 (1.0-4.0)3.0 (1.0-5.0)0.63
        Age at sexual debut, yrs, median (IQR)19.0 (17.0-22.5)19.0 (17.5-20.5)0.99
        Previous STD5 (7)1 (1)0.22
        Previous/current use of hormonal contraception48 (63)34 (51)0.18
        HPV vaccine3 (4)1 (1)0.62
        Ever/current smoking14 (18)10 (15)0.66
        Multiparity30 (39)19 (29)0.22
    Knowledge about CCS
        CCS is performed for the diagnosis of:
                Infection47 (62)30 (45)0.06
                Malignancy51 (67)39 (59)0.38
                SLE-specific features5 (7)12 (18)0.04
    Reasons for not being up to date for CCS
        Not knowing my GPs could perform CCS–24 (36)–
        Not knowing CCS should be repeated, even when normal at first–20 (30)–
        CCS is unpleasant/painful–19 (29)–
        Postponed–17 (26)–
        Cannot get a gynecologist where I live–14 (21)–
        Not being advised by my GP/specialist to have CCS–12 (18)–
        No reason because no hormonal contraception–10 (15)–
        Too many physicians’ appointments8 (12)
        No reason because no sexual relationship–6 (9)–
        Cost–5 (8)–
        Not feeling able to send sample to a laboratory for analysis–2 (3)–
    • Values are expressed as n (%) unless indicated otherwise.

    • ↵a The median time delay between SLE disease assessment and CCS in patients who were not up to date at baseline was 2.5 (range 0.5-8.0) months. CCS: cervical cancer screening; GP: general practitioner; HCQ: hydroxychloroquine; HPV: human papillomavirus; IS: immunosuppressive; LN: lupus nephritis; SLE: systemic lupus erythematosus; SLEDAI: Systemic Lupus Erythematosus Disease Activity Index; STD: sexually transmitted disease.

PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 50, Issue 12
1 Dec 2023
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Improving Human Papillomavirus-Related Cervical Cancer Screening in Patients With Systemic Lupus Erythematosus
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Improving Human Papillomavirus-Related Cervical Cancer Screening in Patients With Systemic Lupus Erythematosus
Tiphaine Goulenok, Céline Mendes, Léa Dayan, Valentine Marie Ferre, Margot Bucau, Fatima Farhi, Thomas Papo, Karim Sacré
The Journal of Rheumatology Dec 2023, 50 (12) 1642-1644; DOI: 10.3899/jrheum.2022-1335

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Improving Human Papillomavirus-Related Cervical Cancer Screening in Patients With Systemic Lupus Erythematosus
Tiphaine Goulenok, Céline Mendes, Léa Dayan, Valentine Marie Ferre, Margot Bucau, Fatima Farhi, Thomas Papo, Karim Sacré
The Journal of Rheumatology Dec 2023, 50 (12) 1642-1644; DOI: 10.3899/jrheum.2022-1335
del.icio.us logo Twitter logo Facebook logo  logo Mendeley logo
  • Tweet Widget
  •  logo
Bookmark this article

Jump to section

  • Article
    • ACKNOWLEDGMENT
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Acrocyanosis After Immunotherapy: Vasculitis or Vasculopathy? New Iatrogenic Disease Case Series From CanRIO
  • The Risk and Time Course for Autoimmune Rheumatic Disease Development in Patients With Raynaud Phenomenon
  • Endothelial Cell and Neutrophil Activation in Untreated Intercritical Patients With Gout
Show more Research Letter

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2025 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire